Citigroup Inc Kaleido Biosciences, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.05 - $1.7 $72 - $2,451
-1,442 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$1.3 - $2.7 $4,585 - $9,522
-3,527 Reduced 70.98%
1,442 $2,000
Q4 2021

Feb 10, 2022
BUY
$2.39 - $6.02 $1,042 - $2,624
436 Added 9.62%
4,969 $12,000
Q3 2021

Nov 10, 2021
BUY
$5.36 - $7.99 $24,296 - $36,218
4,533 New
4,533 $25,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email